Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance

RegulatoryNegative

AI Analysis

Summary

Evogene Ltd. announced that Nasdaq has granted an additional 180-day period to regain minimum bid price compliance, extending the deadline to March 29, 2027. The company specializes in computational chemistry and generative design of small molecules for pharmaceutical and agricultural industries.

Outcome Details

Nasdaq granted additional 180-day period to regain minimum bid price compliance

Importance:3/10

Sentiment:

-0.60

nasdaq compliancestock priceregulatorycomputational chemistry

Related Companies

$EVGN

Read the original article

Published by PR Newswire Biotech on September 30, 2026 11:15 AM

Read Original